IL6 and breast carcinoma: Both primary and lymph node metastasis (N1-N3) of breast cancers promoted MCT-1, PD-L1 and IL-6 expression, while MCT-1 and IL-6 were upregulated in another distant metastasis (M1), supporting their metastatic roles.